Date: 2015-02-10
Type of information: Collaboration agreement
Compound:
Company: Novo Nordisk (Denmark) Karolinska Institutet (Sweden)
Therapeutic area: Metabolic diseases
Type agreement: collaboration
Action mechanism:
Disease: diabetes
Details: * On February 10, 2015, Karolinska Institutet and Novo Nordisk signed a collaboration agreement in the field of diabetes. The programme will be fully funded by Novo Nordisk. In the new international post-doctoral fellowship programme, a total of 12 post-doctoral researchers will be offered a three-year grant to support their research primarily within the field of diabetes and metabolism. The research will be performed at Karolinska Institutet in Stockholm, Sweden, but there will also be possibility for research exchange performed at Novo Nordisk Research and Development in Denmark. A joint steering committee with members from both Karolinska Institutet and Novo Nordisk will oversee the programme and will be responsible for recruiting researchers. The first four fellows in the programme are expected to start in the autumn of 2015.
Financial terms:
Latest news:
